ADRA1D antibody (N-Term)
Quick Overview for ADRA1D antibody (N-Term) (ABIN5539092)
Target
See all ADRA1D AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This ADRA1D antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1-30amino acids from the N-terminal region of human ADRA1D.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
-
For IHC-P starting dilution is: 1:25
For FACS starting dilution is: 1:25
For WB starting dilution is: 1:1000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))
-
Alternative Name
- ADRA1D
-
Background
- This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.
-
Molecular Weight
- 60 kDa
-
Gene ID
- 146
-
UniProt
- P25100
Target
-